Overexpression of LAT1, but not CD98hc, was detected in uterine cervical and bile duct carcinomas, and that of CD98hc, but not LAT1, was noted in glioblastoma, bladder carcinoma, esophagus adenocarcinoma, and Chronophobe renal carcinoma (chRCC) (Supplementary Figure 2). This evidence concerns the gene SLC3A2 and glioblastoma.